Under the leadership of associate Professor at Northumbria University Dr. Stergios of Moschos test device collects breath samples for detection of virus and less prone to contamination and false negative results. The device works about the same as a breathalyzer test: detects alcohol in the breath. Instead of scanning the air for the presence of ethanol, the device works by collecting biological information from a sample of breath, known as biomarkers. If it detects biomarkers such as DNA, RNA, proteins or lipids, it indicates that light can potentially be infected with a virus. The world health organization currently recommends testing patients using swabs from the nose, mouth and lungs (collected when the patient is coughing up mucus). Dr. Moschos and his team believe that “virus detector breathalyzer” will work better in the collection of samples of the stroke.
Experts even say that new technology, if it is improved, can have tremendous impact on health worldwide, not only allowing people to more quickly diagnose viral diseases, but also as a means of diagnosis of other respiratory diseases, including lung disease, liver problems, diabetes, cancer and aging.